title: L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer: Effect of a novel UGT1 marker, rs11563250A > G.
authors.affiliation: Coordenação de Pesquisa, Instituto Nacional de Câncer, Rio de Janeiro, Brazil.|Centro Universitário Estadual da Zona Oeste, Rio de Janeiro, Brazil.
authors.forename: Ana Beatriz
authors.initials: AB
authors.lastname: Santoro
authors.affiliation: Programa de Computação Científica, Fundação Oswaldo Cruz, Rio de Janeiro, Brazil.
authors.forename: Claudio José
authors.initials: CJ
authors.lastname: Struchiner
authors.affiliation: Coordenação de Pesquisa, Instituto Nacional de Câncer, Rio de Janeiro, Brazil. kurtz@inca.gov.br, kurtz.guilherme@gmail.com.
authors.forename: Guilherme
authors.initials: G
authors.lastname: Suarez-Kurtz
mesh_terms: D000328:Adult; D000368:Aged; D000483:Alleles; D005260:Female; D005838:Genotype; D014453:Glucuronosyltransferase / Q000235:genetics*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D013964:Thyroid Neoplasms / Q000188:drug therapy*; D013972:Thyrotropin / Q000037:antagonists & inhibitors*; D013974:Thyroxine / Q000627:therapeutic use*; D014541:Uridine Kinase
chemical_list: D013972:Thyrotropin; D014453:Glucuronosyltransferase; D014541:Uridine Kinase; D013974:Thyroxine